JD Health International, Inc. (6618) Stock Forecast & Price Target

Compare

22 Followers

See the Price Targets and Ratings of:

All Analysts

Top Analysts

Premium

6618 Analyst Ratings

Strong Buy

9 Buy

1 Hold

0 Sell

Based on 10 analysts giving stock ratings to

Health International, Inc.

in the past 3 months

TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months

6618 Stock 12 Month Forecast

Average Price Target

HK$77.36

▲(23.68% Upside)

Based on 10 Wall Street analysts offering 12 month price targets for JD Health International, Inc. in the last 3 months. The average price target is HK$77.36 with a high forecast of HK$95.00 and a low forecast of HK$60.00. The average price target represents a 23.68% change from the last price of HK$62.55.

{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"26":"HK$26","61":"HK$61","96":"HK$96","43.5":"HK$43.5","78.5":"HK$78.5"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":95,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">HK$95.00</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":77.36,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">HK$77.36</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":60,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">HK$60.00</span>\n  </div></div>","useHTML":true}}],"tickPositions":[26,43.5,61,78.5,96],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Jan<br/>2025","6":"May<br/>2025","9":"Aug<br/>2025","12":"Nov<br/>2025","25":"Nov<br/>2026"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,60.7,63.338461538461544,65.97692307692309,68.61538461538461,71.25384615384615,73.8923076923077,76.53076923076924,79.16923076923078,81.8076923076923,84.44615384615385,87.08461538461539,89.72307692307692,92.36153846153846,{"y":95,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,60.7,61.98153846153846,63.26307692307692,64.54461538461538,65.82615384615384,67.1076923076923,68.38923076923078,69.67076923076922,70.9523076923077,72.23384615384616,73.51538461538462,74.79692307692308,76.07846153846154,{"y":77.36,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,60.7,60.64615384615385,60.59230769230769,60.53846153846154,60.48461538461539,60.43076923076923,60.37692307692308,60.323076923076925,60.269230769230774,60.215384615384615,60.16153846153846,60.10769230769231,60.05384615384615,{"y":60,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":35,"date":1727740800000,"info":" <span style=\"color:#828080\" class=\"mb3 mt2 fonth8_semibold\"> Hold</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 2,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#828080","enabled":true,"symbol":"circle"}},{"y":27.6,"date":1730419200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 4,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":29.05,"date":1733011200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Moderate Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 3,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":28.1,"date":1735689600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 3,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":33.8,"date":1740787200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Moderate Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 3,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":32.95,"date":1743465600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 4,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":37.1,"date":1746057600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 7,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":39.8,"date":1748736000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 8,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":43,"date":1751328000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 13,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":48.75,"date":1754006400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 19,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":64.1,"date":1756684800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 17,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":66.5,"date":1759276800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 18,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":60.7,"date":1761955200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 15,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}

Highest Price TargetHK$95.00

Average Price TargetHK$77.36

Lowest Price TargetHK$60.00

The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts

Unknown Analyst

Citic Securities

Not Ranked

Citic Securities

HK$95

Buy

51.88%

Upside

Reiterated

11/20/25

Unknown Analyst

China Renaissance

Not Ranked

China Renaissance

HK$93.29

Buy

49.14%

Upside

Reiterated

11/20/25

JD Health International, Inc. (6618) Receives a Buy from China Renaissance

Unknown Analyst

Nomura

Not Ranked

Nomura

HK$72→HK$80

Buy

27.90%

Upside

Reiterated

11/16/25

Nomura Sticks to Its Buy Rating for JD Health International, Inc. (6618)

Rosa Clinessa

TR | OpenAI - 4o

HK$68→HK$78

Buy

24.70%

Upside

Reiterated

11/15/25

AI Generated ArticleAI Generated Article

Elinor Leung

CLSA

HK$66→HK$71

Buy

13.51%

Upside

Reiterated

11/14/25

Henry Liu, CFA

UBS

HK$78.5→HK$85

Buy

35.89%

Upside

Reiterated

11/14/25

Unknown Analyst

Bank of America Securities

Not Ranked

Bank of America Securities

HK$71→HK$75

Buy

19.90%

Upside

Reiterated

11/14/25

Bank of America Securities Sticks to Its Buy Rating for JD Health International, Inc. (6618)

Unknown Analyst

CICC

Not Ranked

CICC

HK$67.4→HK$71.4

Buy

14.15%

Upside

Reiterated

11/14/25

CICC Remains a Buy on JD Health International, Inc. (6618)

Unknown Analyst

Morgan Stanley

Not Ranked

Morgan Stanley

HK$52.5→HK$60

Hold

-4.08%

Downside

Reiterated

11/13/25

Ellie Jiang

Macquarie

HK$62.14→HK$74.57

Buy

19.22%

Upside

Reiterated

10/17/25

Unknown Analyst

Huatai Securities

Not Ranked

Huatai Securities

HK$68.3

Buy

9.19%

Upside

Reiterated

10/14/25

Unknown Analyst

Nomura

Not Ranked

Nomura

HK$72

Buy

15.11%

Upside

Reiterated

10/13/25

Unknown Analyst

Bank of America Securities

Not Ranked

Bank of America Securities

HK$71

Buy

13.51%

Upside

Reiterated

10/13/25

Unknown Analyst

CICC

Not Ranked

CICC

HK$67.4

Buy

7.75%

Upside

Reiterated

10/13/25

Unknown Analyst

Morgan Stanley

Not Ranked

Morgan Stanley

HK$52.5

Hold

-16.07%

Downside

Reiterated

10/13/25

Ranks

Any

Analyst Rating

Any

Upside/ Downside

Any

Action

Any

Unknown Analyst

Citic Securities

Not Ranked

Citic Securities

HK$95

Buy

51.88%

Upside

Reiterated

11/20/25

Unknown Analyst

China Renaissance

Not Ranked

China Renaissance

HK$93.29

Buy

49.14%

Upside

Reiterated

11/20/25

JD Health International, Inc. (6618) Receives a Buy from China Renaissance

Unknown Analyst

Nomura

Not Ranked

Nomura

HK$72→HK$80

Buy

27.90%

Upside

Reiterated

11/16/25

Nomura Sticks to Its Buy Rating for JD Health International, Inc. (6618)

Rosa Clinessa

TR | OpenAI - 4o

HK$68→HK$78

Buy

24.70%

Upside

Reiterated

11/15/25

AI Generated ArticleAI Generated Article

Elinor Leung

CLSA

HK$66→HK$71

Buy

13.51%

Upside

Reiterated

11/14/25

Henry Liu, CFA

UBS

HK$78.5→HK$85

Buy

35.89%

Upside

Reiterated

11/14/25

Unknown Analyst

Bank of America Securities

Not Ranked

Bank of America Securities

HK$71→HK$75

Buy

19.90%

Upside

Reiterated

11/14/25

Bank of America Securities Sticks to Its Buy Rating for JD Health International, Inc. (6618)

Unknown Analyst

CICC

Not Ranked

CICC

HK$67.4→HK$71.4

Buy

14.15%

Upside

Reiterated

11/14/25

CICC Remains a Buy on JD Health International, Inc. (6618)

Unknown Analyst

Morgan Stanley

Not Ranked

Morgan Stanley

HK$52.5→HK$60

Hold

-4.08%

Downside

Reiterated

11/13/25

Ellie Jiang

Macquarie

HK$62.14→HK$74.57

Buy

19.22%

Upside

Reiterated

10/17/25

Unknown Analyst

Huatai Securities

Not Ranked

Huatai Securities

HK$68.3

Buy

9.19%

Upside

Reiterated

10/14/25

Unknown Analyst

Nomura

Not Ranked

Nomura

HK$72

Buy

15.11%

Upside

Reiterated

10/13/25

Unknown Analyst

Bank of America Securities

Not Ranked

Bank of America Securities

HK$71

Buy

13.51%

Upside

Reiterated

10/13/25

Unknown Analyst

CICC

Not Ranked

CICC

HK$67.4

Buy

7.75%

Upside

Reiterated

10/13/25

Unknown Analyst

Morgan Stanley

Not Ranked

Morgan Stanley

HK$52.5

Hold

-16.07%

Downside

Reiterated

10/13/25

Stocks with the Highest Top Analyst Consensus in the Healthcare Sector

xxx

Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering JD Health International, Inc.

1 Month

xxx

Success Rate

3/3 ratings generated profit

Average Return

+13.97%

reiterated a xxx

rating 3 months ago

Copying xxxxxxxxxxxxxxxxxx

trades and holding each position for 1 Month would result in 100.00% of your transactions generating a profit, with an average return of +13.97% per trade.

3 Months

xxx

Success Rate

3/3 ratings generated profit

Average Return

+33.57%

reiterated a xxx

rating 3 months ago

Copying xxxxxxxxxxxxxxxxxx

trades and holding each position for 3 Months would result in 100.00% of your transactions generating a profit, with an average return of +33.57% per trade.

1 Year

Cui CuiJefferies

Success Rate

3/3 ratings generated profit

Average Return

+68.93%

reiterated a buy rating 3 months ago

Copying Cui Cui's trades and holding each position for 1 Year would result in 100.00% of your transactions generating a profit, with an average return of +68.93% per trade.

2 Years

xxx

Success Rate

3/3 ratings generated profit

Average Return

+68.93%

reiterated a xxx

rating 3 months ago

Copying xxxxxxxxxxxxxxxxxx

trades and holding each position for 2 Years would result in 100.00% of your transactions generating a profit, with an average return of +68.93% per trade.

The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

6618 Analyst Recommendation Trends

Rating

Jul 25

Aug 25

Sep 25

Oct 25

Nov 25

Strong Buy

Buy

Hold

Sell

Strong Sell

total

In the current month, 6618 has received 15 Buy Ratings, 2 Hold Ratings, and 0 Sell Ratings. 6618 average Analyst price target in the past 3 months is 77.36.

Each month's total comprises the sum of three months' worth of ratings.

6618 Financial Forecast

6618 Earnings Forecast

Next quarter’s earnings estimate for 6618 is HK$0.71 with a range of HK$0.71 to HK$0.71. The previous quarter’s EPS was HK$0.89. 6618 beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 57.09% of the time in the same period. In the last calendar year 6618 has Performed in-line its overall industry.

6618 Sales Forecast

Next quarter’s sales forecast for 6618 is HK$39.50B with a range of HK$39.28B to HK$39.75B. The previous quarter’s sales results were HK$37.91B. 6618 beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 47.55% of the time in the same period. In the last calendar year 6618 has Performed in-line its overall industry.

6618 Stock Forecast FAQ

What is HK:6618’s average 12-month price target, according to analysts?

Based on analyst ratings, JD Health International, Inc.’s 12-month average price target is 77.36.

What is HK:6618’s upside potential, based on the analysts’ average price target?

JD Health International, Inc. has 23.68% upside potential, based on the analysts’ average price target.

Can I see which stocks the top-ranking analysts are rating?

Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.

How can I follow the stock ratings of top Wall Street analysts?

Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.

Is JD Health International, Inc. a Buy, Sell or Hold?

JD Health International, Inc. has a consensus rating of Strong Buy, which is based on 9 buy ratings, 1 hold ratings and 0 sell ratings.

What is JD Health International, Inc.’s share price target?

The average share price target for JD Health International, Inc. is 77.36. This is based on 10 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst share price target is HK$95.00 ,and the lowest forecast is HK$60.00. The average share price target represents 23.68% Increase from the current price of HK$62.55.

What do analysts say about JD Health International, Inc.?

JD Health International, Inc.’s analyst rating consensus is a Strong Buy. This is based on the ratings of 10 Wall Streets Analysts.

How can I buy shares of JD Health International, Inc.?

To buy shares of HK:6618, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing

JD Health International, Inc. (6618) Stock Forecast & Price Target

6618 Analyst Ratings

6618 Stock 12 Month Forecast

Average Price Target

Detailed List of Analyst Forecasts​

Best Analysts Covering JD Health International, Inc.

6618 Analyst Recommendation Trends

6618 Financial Forecast

6618 Earnings Forecast

6618 Sales Forecast

6618 Stock Forecast FAQ

Become an Expert with TipRanks Premium

Detailed List of Analyst Forecasts